Symphony Icon Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Symphony Icon General Information
Description
Developer of pharmaceutical products. The company develops pharmaceutical products including LX6171 for cognitive disorders, LX1031 for irritable bowel syndrome and LX1032 for gastrointestinal disorders. It is also engaged in clinical and other related development activities.
Contact Information
Website
www.symphonyicon.comCorporate Office
- 7361 Calhoun Place
- Suite 325
- Rockville, MD 20855
- United States
Corporate Office
- 7361 Calhoun Place
- Suite 325
- Rockville, MD 20855
- United States
Symphony Icon Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Symphony Icon Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Symphony Icon FAQs
-
When was Symphony Icon founded?
Symphony Icon was founded in 2007.
-
Where is Symphony Icon headquartered?
Symphony Icon is headquartered in Rockville, MD.
-
What industry is Symphony Icon in?
Symphony Icon’s primary industry is Pharmaceuticals.
-
Is Symphony Icon a private or public company?
Symphony Icon is a Private company.
-
What is the current valuation of Symphony Icon?
The current valuation of Symphony Icon is .
-
What is Symphony Icon’s current revenue?
The current revenue for Symphony Icon is .
-
Who are Symphony Icon’s investors?
Symphony Capital has invested in Symphony Icon.
-
When was Symphony Icon acquired?
Symphony Icon was acquired on 02-Aug-2010.
-
Who acquired Symphony Icon?
Symphony Icon was acquired by Lexicon Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
